Riluzole Tablet, Film Coated
Product Images NDC 62756-538

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Riluzole (NDC 62756-538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

This is a description for Riluzole Tablets, USP distributed by Sun Pharmaceutical Industries, Inc. The tablets contain 50mg of riluzole USP and are sold in a bottle of 30 tablets. The recommended dosage is one tablet every 12 hours. The tablets are manufactured by Sun Pharmaceutical Industries Ltd. in Halol-Baroda Highway, Gujarat, India. The tablets should be stored at a temperature between 20° and 25°C (68° and 77°F) and protected from bright light. This medication should be kept out of reach of children.*

FDA Label Image

Spl-riluzole-figure1 (Spl Riluzole Figure1)

This text presents data on survival probability with a visualization of Kaplan-Meier Survival Curves for Riluzole at 50 mg taken twice daily compared with a placebo group with a sample size of 77 and 78 respectively.*

FDA Label Image

Spl-riluzole-figure2 (Spl Riluzole Figure2)

This appears to be a graph showing Kaplan-Meier Survival Curves for Riluzole 50mg twice daily (N=236) versus Placebo (N=242). The text indicates a survival probability of 0.7 and there are numbers and symbols that are not legible. Without further context, it is difficult to provide a more detailed description.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.